Viva papers

Rivaroxaban vs warfarin in AF; non inferiority study with lower risk of intracranial haemorrhage, outcome points at 12-24 months

Comparison of rivaroxaban vs enoxaparin and vitK antagonist, randomised and controlled... Outcome of non inferiority and possibly superior outcomes of major bleeding events

Dabigatran vs warfarin in metallic valves: trial stopped early as 5% in dabigatran arm developed ischaemic stroke vs those who had warfarin (0%). Outcome data at three months